Why Is Moderna Stock Trading Lower On Friday? – Moderna (NASDAQ:MRNA)
Thursday, Moderna Inc MRNA unveiled key updates at its annual R&D Day by reducing annual R&D spending by $1.1 billion by 2027, enabling a focus on ten prioritized products. The company expects R&D expenses to fall from $4.8 billion in 2024E to $3.6 billion—$3.8 billion in 2027. The strategy, expanding its portfolio into oncology and rare diseases, positions … Read more